Dr. Dana Hassouneh , King Hussein Cancer Center , Jordan
Dana Hassouneh is a dedicated Clinical Pharmacist from Amman, Jordan, with extensive experience working in hospitals, clinics, and community pharmacies. Passionate about patient-centered care, Dana is committed to enhancing medication therapies while continuously expanding her medical knowledge. Dana’s professional expertise includes inpatient pharmacy, chemotherapy, patient counseling, and drug interactions. As a co-investigator in research, she is also deeply involved in improving healthcare outcomes, particularly in oncology. Dana’s strong communication, organizational, and counseling skills have made her a valuable asset in the healthcare field. She is an advocate for educating patients and healthcare professionals to ensure proper medication use and adherence to prescribed therapies.
Publication Profile:
Orcid
Strengths for the Award 💪
Dana Hassouneh exhibits a strong commitment to patient-centered care and advanced research in the field of clinical pharmacy, particularly in oncology and infectious diseases. Her contributions as a co-investigator in high-impact research, such as the study on microbiological profiles and resistance patterns in pediatric cancer patients, reflect her deep analytical skills and her dedication to improving patient outcomes. Dana’s ability to bridge the gap between clinical practice and research is a standout feature, making her an invaluable asset to the medical community. Her research at the King Hussein Cancer Center, which includes investigating community-acquired pneumonia in cancer patients, demonstrates her ability to approach complex medical problems with a scientific mindset and her willingness to engage in meaningful work to advance healthcare.
Areas for Improvements 🌱
While Dana’s expertise is remarkable, there is always room to expand her research focus and broaden her collaborative network. Increasing her involvement in multi-center, international research collaborations could offer her exposure to a wider variety of data and perspectives, further strengthening her research abilities. Moreover, refining advanced statistical analysis skills and gaining additional training in emerging research methodologies could contribute to more robust and innovative findings. Dana could also consider focusing on improving interdisciplinary collaborations, especially between clinical pharmacy, microbiology, and oncology to enhance her ability to address multifaceted medical challenges.
Education 🎓
Dana graduated from the University of Jordan with a Clinical Pharmacist degree in 2021, achieving an impressive 3.69/4 GPA. Prior to this, she completed her IGCSE studies at Global International School, where she earned a remarkable score of 97.6/100. Throughout her academic journey, Dana has demonstrated exceptional skills in pharmacology and therapeutic practices, laying the foundation for her successful career as a clinical pharmacist. Her education has enabled her to integrate evidence-based medicine into her practice while developing the skills necessary for medication therapy management and patient education. Dana’s academic excellence continues to influence her ongoing professional growth, furthering her ability to contribute to the medical field and improve patient outcomes.
Experience 💼
Dana’s career began at Luqman Al-Hakeem Pharmacy, where she gained valuable patient interaction skills while dispensing medications and offering counseling. Later, as a clinical pharmacist at the King Hussein Cancer Center, Dana worked both in inpatient and chemotherapy pharmacies, ensuring safe medication therapy for cancer patients. Her role involved educating healthcare professionals about drug interactions and alternative therapies. Dana’s research experience as a co-investigator has also been significant, analyzing patient outcomes for those with community-acquired pneumonia. She has also trained at various healthcare settings such as Jordan University Hospital and Jordanian Royal Medical Services, enhancing her knowledge of patient medication management and adherence. This diverse experience has honed Dana’s clinical expertise and strengthened her passion for improving patient care and outcomes.
Research Focus 🔬
Dana’s research primarily focuses on improving patient outcomes through medication therapy management and investigating disease-specific therapies. Her recent work as a co-investigator at King Hussein Cancer Center involves studying the characteristics and outcomes of patients with community-acquired pneumonia. Dana is deeply engaged in the process of manuscript writing and data analysis, with a focus on oncology and infectious diseases. She has also contributed to research regarding microbiological profiles and resistance patterns in pediatric cancer patients. Her research aims to provide evidence-based solutions that can enhance treatment protocols, reduce medication errors, and optimize healthcare delivery for cancer patients. Dana’s work contributes to bridging the gap between clinical practice and research, ensuring that patients receive the best possible care based on up-to-date scientific evidence.
Publications Top Notes 📚
Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan – Cancer Reports (2025-03)
Dana Hassouneh’s blend of clinical practice and research expertise makes her an excellent candidate for the Research for Best Researcher Award. Her strengths in patient education, counseling, and collaboration with multidisciplinary teams position her as an emerging leader in the field. As she continues to develop her research focus and expands her skill set, Dana is poised to contribute significantly to advancements in clinical pharmacy and oncology research. Her passion, diligence, and commitment to improving patient care are undeniable, making her a valuable asset to the healthcare field.